Publications

Results 1-16 of 16 (Search time: 0.004 seconds).

Issue DateTitleAuthor(s)
11-Jul-2012Adiponectin, non-esterified fatty acids and antiphospholipid antibodies in type II diabetes mellitusMirjana Bećarević ; Jelena Seferović; Svetlana Ignjatović; Sandra Singh; Nada Majkić-Singh
21-Sep-2019Adiponectin: a therapeutic target in the antiphospholipid syndrome?Mirjana Bećarević ; Božana Nikolić ; Svetlana Ignjatović
31-Dec-2018Anti-annexin A5 antibodies and 25-hydroxy-cholecalciferol in female patients with primary antiphospholipid syndromeMirjana Bećarević ; Marija Sarić; Ljudmila Stojanović; Duško Mirković; Violeta Dopsaj; Svetlana Ignjatović
41-Jul-2017Antibodies Against Complement Components: Relevance for the Antiphospholipid Syndrome—Biomarkers of the Disease and BiopharmaceuticalsMirjana Bećarević 
51-May-2017Antiphospholipid Antibodies and Renal Impairment Parameters in Diabetic Nephropathy: Preliminary DataMirjana Bećarević ; Velibor Čabarkapa ; Mirjana Đerić ; Svetlana Ignjatović
61-Apr-2013Apoptosis, annexin a5 and anti-Annexin a5 antibodies in the antiphospholipid syndromeMirjana Bećarević ; Svetlana Ignjatović; Nada Majkić-Singh
712-Nov-2012Deterioration of thromboses in primary antiphospholipid syndrome: TNF-alpha and anti-annexin A5 antibodiesMirjana Bećarević ; Svetlana Ignjatović; Nada Majkić-Singh
81-Nov-2017Detrimental roles of TNF-alpha in the antiphospholipid syndrome and de novo synthesis of antiphospholipid antibodies induced by biopharmaceuticals against TNF-alphaMirjana Bećarević 
91-Dec-2016Double positivity of the IgG isotype of both anticardiolipin and anti-β2gpI antibodies is associated with the highest number of vascular impairment parameters in patients with primary antiphospholipid syndrome: preliminary dataMirjana Bećarević ; Duško Mirković; Svetlana Ignjatović
101-Aug-2018Exposure to potential drug-antimicrobial agent interactions in primary health careBožana Nikolić ; Jovan Popović; Mirjana Bećarević ; Dušica Rakić 
111-Nov-2016The IgG and IgM isotypes of anti-annexin A5 antibodies: relevance for primary antiphospholipid syndromeBećarević, Mirjana 
121-May-2016The IgM isotype of anti-annexin A5 antibodies and multiple positivity of conventional antiphospholipid antibodies: increasing the number of clinical manifestations of primary antiphospholipid syndromeMirjana Bećarević ; Ljudmila Stojanović; Svetlana Ignjatović; Violeta Dopsaj
131-Jan-2017pKa values of hyodeoxycholic and cholic acids in the binary mixed micelles sodium-hyodeoxycholate–Tween 40 and sodium-cholate–Tween 40: Thermodynamic stability of the micelle and the cooperative hydrogen bond formation with the steroid skeletonMihalj Poša ; Ana Pilipović ; Mirjana Bećarević ; Zita Farkaš Agatić 
141-Oct-2016Proinflammatory proteins in female and male patients with primary antiphospholipid syndrome: preliminary dataMirjana Bećarević ; Svetlana Ignjatović
151-Aug-2011Significant association of antiphospholipid antibodies and TNF-alpha: Marker of severe atherogenic profile of patients with type II diabetes mellitus without micro and/or macrovascular complicationsMirjana Bećarević ; Jelena Seferović; Svetlana Ignjatović; Sandra Singh; Nada Majkić-Singh
161-Dec-2016TNF-alpha and annexin A2: inflammation in thrombotic primary antiphospholipid syndromeBećarević, Mirjana